---
title: "Psych News Alert: Ketamine Findings Open New Doors to Antidepressant Research"
description: Research suggesting that the anesthetic drug ketamine acts quickly to reduce depressive symptoms is now being supplemented by studies into o...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/Ketamine_159232241-Jun-24-2025-04-13-46-4307-PM.jpg
---

 11/20/13 12:00 AM

# Ketamine Findings Open New Doors to Antidepressant Research

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html)

| [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/Ketamine_159232241-Jun-24-2025-04-13-47-1334-PM.jpg?width=200&name=Ketamine_159232241-Jun-24-2025-04-13-47-1334-PM.jpg)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/Ketamine_159232241-Jun-24-2025-04-13-47-1334-PM.jpg) |  |
| --- | --- |

Research suggesting that the anesthetic drug ketamine acts quickly to reduce depressive symptoms is now being supplemented by studies into other substances that operate on similar pathways, according to two reports in the current issue of *[Biological Psychiatry](http://www.biologicalpsychiatryjournal.com/issues?issue_key=S0006-3223(13)X0020-4)*.

One [study of depressed patients](http://www.biologicalpsychiatryjournal.com/article/S0006-3223(13)00188-1/abstract) by scientists from Taiwan’s China Medical University and from UCLA found that sarcosine improved mood scores and reduced depressive symptoms, when compared with patients taking the antidepressant citalopram. Sarcosine’s effects, however, are the opposite of ketamine’s. Sarcosine enhances activity of the NMDA glutamate receptor, while ketamine blocks it. Further research is needed to clarify these paradoxical outcomes, said John Krystal, M.D., the journal’s editor.

The [second study](http://www.biologicalpsychiatryjournal.com/article/S0006-3223(13)00404-6/abstract) noted that prior research identified the mammalian target of rapamycin (mTOR) as a key mediator of the antidepressant effects of ketamine. Researchers led by Ronald Duman, Ph.D., a professor of psychiatry, neurobiology, and pharmacology at Yale University School of Medicine, found that scopolamine, a muscarinic acetylcholine receptor antagonist, caused rapid activation of mTOR signaling and increased the number of synaptic connections in the prefrontal cortex.

"These effects are similar to the actions of ketamine, showing that two drugs with completely different receptor blocking profiles have common downstream actions linked to rapid antidepressant responses," said Duman in a statement. "Moreover, the increase in synaptic connections reverses the deficit caused by stress and depression and thereby reinstates the normal control of mood and emotion."

To read more about recent research on ketamine, see the *Psychiatric News* article “[Ketamine Shows Rapid Action In Treatment-Resistant Depression](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1739062).” Also see the study   
["Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial"](http://ajp.psychiatryonline.org/article.aspx?articleid=1733362) in the *American Journal of Psychiatry*.

 

   

 

Image: Iculig/Shutterstock.com)

[ketamine](https://alert.psychnews.org/tag/ketamine), [depression](https://alert.psychnews.org/tag/depression), [Biological Psychiatry](https://alert.psychnews.org/tag/biological-psychiatry), [scopolamine](https://alert.psychnews.org/tag/scopolamine), [NMDA glutamate receptor](https://alert.psychnews.org/tag/nmda-glutamate-receptor), [Ronald Duman](https://alert.psychnews.org/tag/ronald-duman), [sarcosine](https://alert.psychnews.org/tag/sarcosine), [mTOR](https://alert.psychnews.org/tag/mtor)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/IV%20drip_iStock_00002009034-Jun-24-2025-03-52-30-1371-PM.jpg?height=200&name=IV%20drip_iStock_00002009034-Jun-24-2025-03-52-30-1371-PM.jpg) ](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

[suicide](https://alert.psychnews.org/tag/suicide), [ketamine](https://alert.psychnews.org/tag/ketamine), [depression](https://alert.psychnews.org/tag/depression), [suicidal ideation](https://alert.psychnews.org/tag/suicidal-ideation), [depression treatment](https://alert.psychnews.org/tag/depression-treatment)

## [Ketamine May Reduce Active Suicidal Thoughts in Patients With Treatment-Resistant Depression](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/24/24 11:16 AM

Ketamine may be able to rapidly reduce persistent suicidal thoughts in medicated patients with...

[ Read more ](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/IV%20drip_iStock_00002009034-Jun-24-2025-03-54-38-2571-PM.jpg?height=200&name=IV%20drip_iStock_00002009034-Jun-24-2025-03-54-38-2571-PM.jpg) ](https://alert.psychnews.org/2016/04/study-identifies-ketamine-dosing.html)

[APA](https://alert.psychnews.org/tag/apa), [psychiatry](https://alert.psychnews.org/tag/psychiatry), [ketamine](https://alert.psychnews.org/tag/ketamine), [depression](https://alert.psychnews.org/tag/depression), [American Journal of Psychiatry](https://alert.psychnews.org/tag/american-journal-of-psychiatry), [clinical trial](https://alert.psychnews.org/tag/clinical-trial), [MADRS](https://alert.psychnews.org/tag/madrs), [Jannsen Research and Development](https://alert.psychnews.org/tag/jannsen-research-and-development), [Jaskaran Singh](https://alert.psychnews.org/tag/jaskaran-singh), [antidepressant medication](https://alert.psychnews.org/tag/antidepressant-medication)

## [Study Identifies Ketamine Dosing Frequencies for Maintaining Efficacy Over 15 Days](https://alert.psychnews.org/2016/04/study-identifies-ketamine-dosing.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 4/8/16 12:00 AM

Single infusions of ketamine have been shown to produce a rapid antidepressant effect, but past...

[ Read more ](https://alert.psychnews.org/2016/04/study-identifies-ketamine-dosing.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/feder_2014-Jun-24-2025-03-51-35-8567-PM.jpg?height=200&name=feder_2014-Jun-24-2025-03-51-35-8567-PM.jpg) ](https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html)

[ketamine](https://alert.psychnews.org/tag/ketamine), [PTSD](https://alert.psychnews.org/tag/ptsd), [JAMA Psychiatry](https://alert.psychnews.org/tag/jama-psychiatry)

## [Intravenous Ketamine May Be Effective in Treating Chronic PTSD, Preliminary Study Suggests](https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/24/24 11:16 AM

Intravenous ketamine appears to produce rapid reduction in symptom severity in patients with...

[ Read more ](https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T16:18:15.537Z",
  "datePublished" : "2013-11-20T05:00:00.000Z",
  "headline" : "Psych News Alert: Ketamine Findings Open New Doors to Antidepressant Research",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/Ketamine_159232241-Jun-24-2025-04-13-46-4307-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2013/11/ketamine-findings-open-new-doors-to.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```